Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Losdat

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Interventions|February 26, 2020
Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography StudyYasushi Ueki, Lorenz Räber, Tatsuhiko Otsuka, et al.
Plos One|February 16, 2022
Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classificationYasushi Ueki, Thomas Zanchin, Sylvain Losdat, et al.
Plos One|March 4, 2022
The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort studyUlrike Held, Klaus Steigmiller, Michael Hediger, et al.
Journal of the American Heart Association|August 24, 2022
Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition in Patients With Acute Anterior Myocardial Infarction: Final 1-Year Outcomes of the Randomized CARE-AMI TrialThomas Pilgrim, Benedikt Bernhard, Monika Fürholz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 3, 2021
Impact of Intracoronary Optical Coherence Tomography in Routine Clinical Practice: A Contemporary Cohort StudyJonas D Häner, Benjamin Duband, Yasushi Ueki, et al.
American Heart Journal|March 11, 2026
IMPACT OF TOTAL STENT LENGTH ON LONG-TERM OUTCOMES WITH DIFFERENT NEWER-GENERATION DRUG-ELUTING STENT DESIGNS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A SUBGROUP ANALYSIS FROM THE BIOSTEMI ES RANDOMIZED TRIALJuan F Iglesias, Marco Roffi, Dik Heg, et al.
American Heart Journal|May 16, 2023
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trialsJonas D Häner, Miklos Rohla, Sylvain Losdat, et al.
Journal of the American Heart Association|December 29, 2023
Quantitative Flow Ratio to Predict Non-Target-Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeSarah Bär, Raminta Kavaliauskaite, Tatsuhiko Otsuka, et al.
JACC. Cardiovascular Interventions|March 17, 2021
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI TrialThomas Pilgrim, Olivier Muller, Dik Heg, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Interventions|February 26, 2020
Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography StudyYasushi Ueki, Lorenz Räber, Tatsuhiko Otsuka, et al.
Plos One|February 16, 2022
Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classificationYasushi Ueki, Thomas Zanchin, Sylvain Losdat, et al.
Plos One|March 4, 2022
The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort studyUlrike Held, Klaus Steigmiller, Michael Hediger, et al.
Journal of the American Heart Association|August 24, 2022
Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition in Patients With Acute Anterior Myocardial Infarction: Final 1-Year Outcomes of the Randomized CARE-AMI TrialThomas Pilgrim, Benedikt Bernhard, Monika Fürholz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 3, 2021
Impact of Intracoronary Optical Coherence Tomography in Routine Clinical Practice: A Contemporary Cohort StudyJonas D Häner, Benjamin Duband, Yasushi Ueki, et al.
American Heart Journal|March 11, 2026
IMPACT OF TOTAL STENT LENGTH ON LONG-TERM OUTCOMES WITH DIFFERENT NEWER-GENERATION DRUG-ELUTING STENT DESIGNS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A SUBGROUP ANALYSIS FROM THE BIOSTEMI ES RANDOMIZED TRIALJuan F Iglesias, Marco Roffi, Dik Heg, et al.
American Heart Journal|May 16, 2023
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trialsJonas D Häner, Miklos Rohla, Sylvain Losdat, et al.
Journal of the American Heart Association|December 29, 2023
Quantitative Flow Ratio to Predict Non-Target-Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeSarah Bär, Raminta Kavaliauskaite, Tatsuhiko Otsuka, et al.
JACC. Cardiovascular Interventions|March 17, 2021
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI TrialThomas Pilgrim, Olivier Muller, Dik Heg, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Pageof 7